Dec 08, 2020 8:30am EST Artelo Biosciences to Present at The 13th Annual LD Micro Main Event Conference on December 15th
Dec 02, 2020 8:30am EST Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors
Nov 23, 2020 8:30am EST Artelo Biosciences and University of Western Ontario Awarded Research Grant by Mitacs
Nov 16, 2020 8:30am EST Artelo Biosciences Announces Clinical Trial Authorization to Commence Cancer Appetite Recovery Study for the Treatment of Cancer-Related Anorexia and Weight Loss
Nov 11, 2020 8:30am EST Artelo Biosciences to Present at the Virtual Fall Investor Summit on November 18th
Nov 04, 2020 8:00am EST Artelo Biosciences Reports Fourth Quarter and Fiscal 2020 Year-End Financial Results and Provides Business Update
Oct 21, 2020 8:30am EDT Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders
Oct 14, 2020 4:05pm EDT Artelo Biosciences, Inc. Announces Closing of $7.6 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option
Oct 09, 2020 8:30am EDT Artelo Biosciences, Inc. Announces Pricing of $6.6 Million Upsized Underwritten Public Offering
